Back to Search
Start Over
Adipose-mesenchymal stromal cells suppress experimental Sjögren syndrome by IL-33-driven expansion of ST2+ regulatory T cells
- Source :
- iScience, Vol 24, Iss 5, Pp 102446-(2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- Summary Adipose-derived mesenchymal stromal cells (ADSCs) play important roles in the alleviation of inflammation and autoimmune diseases. Interleukin-33 (IL-33), a member of the IL-1 family, has been shown to regulate innate and adaptive immunity. However, it is still unknown whether ADSCs regulate immune responses via IL-33. We show here that ADSCs produced IL-33 in response to IL-1β stimulation, which depended on TAK1, ERK, and p38 pathways. ADSCs-derived IL-33 drove the proliferation of CD4+Foxp3+ST2+ regulatory T cells (Tregs) and alleviated experimental autoimmune Sjogren’s Syndrome (SS) in mice. Importantly, human ADSCs also produced IL-33 in response to IL-1β. Thus, we have revealed a previously unrecognized immunoregulatory function of ADSCs by IL-33 production in experimental autoimmunity, which may have clinical applications for human immunopathology.
- Subjects :
- 0301 basic medicine
MAPK/ERK pathway
Multidisciplinary
Science
Immunology
Mesenchymal stem cell
Adipose tissue
FOXP3
Cell Biology
02 engineering and technology
Biology
021001 nanoscience & nanotechnology
medicine.disease_cause
Acquired immune system
Autoimmunity
Interleukin 33
03 medical and health sciences
030104 developmental biology
Immune system
Cancer research
medicine
0210 nano-technology
Subjects
Details
- ISSN :
- 25890042
- Volume :
- 24
- Database :
- OpenAIRE
- Journal :
- iScience
- Accession number :
- edsair.doi.dedup.....510ab3459557641f0b911d8b83a47b26